Zynerba_Logo-spot_coated_flat_tagline-01.png
Zynerba Pharmaceuticals Announces Positive Top Line Results from Exploratory Open Label Phase 2 BRIGHT Trial of Zygel in Autism Spectrum Disorder
May 27, 2020 06:45 ET | Zynerba Pharmaceuticals, Inc.
- The BRIGHT Trial Achieved Statistically Significant and Clinically Meaningful Improvements from Baseline in All Subscales of the Aberrant Behavior Checklist - - Safety Data Reinforce...
BRIGHT Figure 1
Zynerba Pharmaceuticals Presents Data Showing that the Baseline Characteristics of Patients in Phase 2 BRIGHT Trial in Autism Spectrum Disorder Indicate a Moderate-to-Severe Study Population
March 03, 2020 12:07 ET | Zynerba Pharmaceuticals, Inc.
DEVON, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and...
6265.jpg
Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
June 28, 2019 08:32 ET | Q BioMed Inc.
Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA) NEW YORK, June 28, 2019 (GLOBE...
Zynerba_Logo-spot_coated_flat_tagline-01.png
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Cannabidiol
June 11, 2019 07:00 ET | Zynerba Pharmaceuticals, Inc.
DEVON, Pa., June 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare...
Zynerba_Logo-spot_coated_flat_tagline-01.png
Zynerba Pharmaceuticals Initiates Phase 2 Trial of Zygel™ in Autism Spectrum Disorder
March 07, 2019 07:00 ET | Zynerba Pharmaceuticals, Inc.
- Topline Data from BRIGHT Study Expected in the First Half 2020 - - Company Selects Zygel™ as Brand Name for ZYN002 CBD Transdermal Gel - DEVON, Pa., March 07, 2019 (GLOBE NEWSWIRE) -- Zynerba...
Elsevier Shines Light on Autism Treatments with New Book Series
July 11, 2017 04:00 ET | Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - July 11, 2017) - Elsevier, the information analytics company specializing in science and health, today announced the publication of a new book series, Critical...
ASC New Logo 2020_1602271173038.jpg
Autism Speaks Canada Walk Will Raise Funds and Spread Awareness about Autism - Support this important FUNdraiser
May 25, 2016 09:25 ET | Autism Speaks Canada
OTTAWA, May 25, 2016 (GLOBE NEWSWIRE) -- Autism Speaks Canada, part of North America's largest autism science and advocacy organization, announced that the Autism Speaks Canada Walk, Ottawa 2016...
Fullerton Cares logo
Charitable "Believe in Yourself" Clothing Line Launched in Support of Fullerton Cares Autism Foundation
March 09, 2015 07:00 ET | Fullerton Cares
FULLERTON, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- With autism affecting 1:68 children, the child of Fullerton Cares founder Larry Houser is far from being just a number. After inspiring the...
HempMeds Logo
Trending: Cannabis Products Hit Convenience and Retail Stores
July 31, 2014 09:00 ET | HempMeds
SAN DIEGO, July 31, 2014 (GLOBE NEWSWIRE) -- Global retailers are seeing what is trending in worldwide news headlines: cannabidiol (CBD), a natural constituent of the hemp plant. Countering claims...
Shema Kolainu Raises the Voice of Autism at Legislative Breakfast
July 29, 2014 17:43 ET | Shema Kolainu - Hear Our Voices
NEW YORK, NY--(Marketwired - Jul 29, 2014) - Shema Kolainu - Hear Our Voices (SKHOV) hosted its 12th Annual Legislative Breakfast at the Renaissance Ballroom in Brooklyn, New York. Over 150 guests...